BRAWN (BRAWN) Fair Value & Analysis
· Market cap ₹59.3M
Fair value as of: Jul 5, 2026
From 15 valuation models · updated today
Share price −6.2% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹16.66 – ₹24.35 · fair‑value band ₹21.32 – ₹61.78 · the ₹19.75 price screens below the ₹26.06 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
BRAWN (BRAWN) currently trades at ₹19.75, while our model-based Fair Value estimate is ₹26.06 — implying the stock looks roughly 31.9% undervalued today. We read business quality at 56/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, BRAWN generated revenue of ₹170M at a net margin of 5.5%. Revenue declined 12.9% year over year. It earns a return on equity of 24.4%. The stock trades on a trailing P/E of 6.1. Fundamentals as of Jul 5, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
BRAWN reported revenue of ₹170M in FY2026 versus ₹79.5M in FY2022, a compound +20.9%/yr. Reported net income was ₹9.4M in FY2026.
Is BRAWN fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is BRAWN (BRAWN) undervalued?
What is the fair value of BRAWN?
What is the quality score of BRAWN?
What is the revenue of BRAWN (BRAWN)?
What is the net profit margin of BRAWN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.